236 related articles for article (PubMed ID: 25139279)
1. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery.
Millotti G; Laffleur F; Perera G; Vigl C; Pickl K; Sinner F; Bernkop-Schnürch A
J Pharm Sci; 2014 Oct; 103(10):3165-70. PubMed ID: 25139279
[TBL] [Abstract][Full Text] [Related]
2. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
3. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan.
Dünnhaupt S; Barthelmes J; Iqbal J; Perera G; Thurner CC; Friedl H; Bernkop-Schnürch A
J Control Release; 2012 Jun; 160(3):477-85. PubMed ID: 22542699
[TBL] [Abstract][Full Text] [Related]
5. S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery.
Perrone M; Lopalco A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Bernkop-Schnürch A; Denora N
Eur J Pharm Biopharm; 2018 Nov; 132():103-111. PubMed ID: 30253185
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
[TBL] [Abstract][Full Text] [Related]
7. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
8. Entirely S-protected chitosan: A promising mucoadhesive excipient for metronidazole vaginal tablets.
Lupo N; Fodor B; Muhammad I; Yaqoob M; Matuszczak B; Bernkop-Schnürch A
Acta Biomater; 2017 Dec; 64():106-115. PubMed ID: 29030305
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
Krauland AH; Leitner VM; Grabovac V; Bernkop-Schnürch A
J Pharm Sci; 2006 Nov; 95(11):2463-72. PubMed ID: 16886206
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
11. Thiolated and S-protected hydrophobically modified cross-linked poly(acrylic acid)--a new generation of multifunctional polymers.
Bonengel S; Haupstein S; Perera G; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2014 Oct; 88(2):390-6. PubMed ID: 24960111
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the efficiency of thiomers: Utilizing a highly mucoadhesive polymer as backbone for thiolation and preactivation.
Prüfert F; Bonengel S; Menzel C; Bernkop-Schnürch A
Eur J Pharm Sci; 2017 Jan; 96():309-315. PubMed ID: 27702609
[TBL] [Abstract][Full Text] [Related]
13. Thiolated pectins: In vitro and ex vivo evaluation of three generations of thiomers.
Knoll P; Le NN; Wibel R; Baus RA; Kali G; Asim MH; Bernkop-Schnürch A
Acta Biomater; 2021 Nov; 135():139-149. PubMed ID: 34418540
[TBL] [Abstract][Full Text] [Related]
14. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
15. 2,2'Dithiodinicotinyl ligands: Key to more reactive thiomers.
Menzel C; Silbernagl J; Laffleur F; Leichner C; Jelkmann M; Huck CW; Hussain S; Bernkop-Schnürch A
Int J Pharm; 2016 Apr; 503(1-2):199-206. PubMed ID: 26972378
[TBL] [Abstract][Full Text] [Related]
16. Thiomers for oral delivery of hydrophilic macromolecular drugs.
Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K
Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of pH tolerant and mucoadhesive (thiol-polyethylene glycol) chitosan graft polymer for drug delivery.
Hauptstein S; Bonengel S; Griessinger J; Bernkop-Schnürch A
J Pharm Sci; 2014 Feb; 103(2):594-601. PubMed ID: 24382680
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
Roldo M; Hornof M; Caliceti P; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2004 Jan; 57(1):115-21. PubMed ID: 14729087
[TBL] [Abstract][Full Text] [Related]
19. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
